Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases

By Shih Andrew J.   Telesco Shannon E.   Radhakrishnan Ravi  

Cancers, Vol. 3, Iss. 1, 2011-03 ,pp. : 1195-1231

MDPI

Access to resources Recommend Favorite

Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab

By Hughes Juliana Bentes   Rødland Marianne Skeie   Hasmann Max   Madshus Inger Helene   Stang Espen  

Pharmaceuticals, Vol. 5, Iss. 7, 2012-06 ,pp. : 674-689

MDPI

Access to resources Recommend Favorite

Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer

By Lv Quanxia   Meng Ziyuan   Yu Yuanyuan   Jiang Feng   Guan Daogang   Liang Chao   Zhou Junwei   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2095-2095

MDPI

Access to resources Recommend Favorite

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.

By Kim Hiyoung   Kim Kwang-Jin   Yeon Jeong-Tae   Kim Seong Hwan   Won Dong Hwan   Choi Hyukjae   Nam Sang-Jip   Son Young-Jin   Kang Heonjoong  

Marine Drugs, Vol. 12, Iss. 4, 2014-04 ,pp. : 2054-2065

MDPI

Access to resources Recommend Favorite

Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action

By Kline Christina Leah B.   El-Deiry Wafik S.  

Pharmaceuticals, Vol. 6, Iss. 8, 2013-08 ,pp. : 988-1038

MDPI

Access to resources Recommend Favorite